Shawn Tomasello's Net Worth

$20.9 Million

Estimate Recalculated Jul 22, 2024 03:32PM EST

Who is Shawn Tomasello?

Shawn Tomasello has an estimated net worth of $20.9 Million. This is based on reported shares across multiple companies, which include Gamida Cell Ltd., Allovir, Inc., 4D Molecular Therapeutics, Inc., Diplomat Pharmacy, Inc., UroGen Pharma Ltd., TCR2 THERAPEUTICS INC., Principia Biopharma Inc., Kite Pharma, Inc., ABEONA THERAPEUTICS INC., Cabaletta Bio, Inc., and PHARMACYCLICS INC.

SEC CIK

Shawn Tomasello's CIK is 0001617239

Past Insider Trading and Trends

2023 was Shawn Tomasello's most active year for acquiring shares with 9 total transactions. Shawn Tomasello's most active month to acquire stocks was the month of May. 2017 was Shawn Tomasello's most active year for disposing of shares, totalling 7 transactions. Shawn Tomasello's most active month to dispose stocks was the month of April. 2022 saw Shawn Tomasello paying a total of $14,999.35 for 132,977 shares, this is the most they've acquired in one year. In 2015 Shawn Tomasello cashed out on 157,504 shares for a total of $15,022,920.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Gamida Cell Ltd. (GMDA) Snapshot price: $0.37

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+476.45%
200K
—
—
241.98K
Jan 31
Form 4/A
—
0
—
—
0
Oct 19
Form 4/A
+206.92%
28.3K
—
—
41.98K
Oct 19
Form 4
—
0
—
—
0
Mar 20
Form 4
+206.92%
28.3K
—
—
41.98K
Feb 8
Form 4
+17.13%
2K
—
—
13.68K
Nov 18
Form 4
+483.85%
9.68K
$1.55
$14,999.35
11.68K
Sep 30
Form 3
—
0
—
—
0
No matching records found

Allovir, Inc. (ALVR) Snapshot price: $0.6739

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+100.00%
35K
—
—
70K
Jun 6
Form 4
∞
35K
—
—
35K
May 11
Form 4
—
0
—
—
0
May 17
Form 4
—
0
—
—
0
Mar 29
Form 3
—
0
—
—
0
No matching records found

4D Molecular Therapeutics, Inc. (FDMT) Snapshot price: $28.4701

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
May 21
Form 4
—
0
—
—
0
May 23
Form 4
—
0
—
—
0
May 23
Form 4
—
0
—
—
0
May 17
Form 3
—
0
—
—
0
No matching records found

Diplomat Pharmacy, Inc. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-44.54K
$4.00
-$178,148.00
0
Feb 10
Form 4
-1.89%
-859.00
$4.84
-$4,157.56
44.54K
Oct 2
Form 4
+238.50%
31.98K
$4.85
-$6,184.76
45.4K
Jun 3 - Jun 4
Form 4
+20.43%
2.27K
—
—
13.41K
Oct 1
Form 4
+21.55%
1.97K
$24.27
-$40,765.87
11.14K
Jun 1 - Jun 5
Form 4
+106.35%
4.72K
—
—
9.16K
Jun 1
Form 4
+50.15%
1.48K
—
—
4.44K
Jun 1
Form 4
∞
2.96K
—
—
2.96K
Oct 6
Form 3
—
0
—
—
0
No matching records found

UroGen Pharma Ltd. (URGN) Snapshot price: $15.8

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 7
Form 4
—
0
—
—
0
Jun 8
Form 4
—
0
—
—
0
Jun 3
Form 3
—
0
—
—
0
No matching records found